EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

WWOX maintains epidermal identity and suppresses EMT to prevent aggressive cutaneous squamous cell carcinoma

Tirza Bidany-Mizrahi iD, Kian Maroun, Mara Mancini iD, Osama Hidmi iD, Ihab Ansari, Jonathan Monin, Tal Keidar Haran, Alexander Maly, Gerry Melino iD, Eleonora Candi iD, Rami I Aqeilan iD

Proceedings of the National Academy of Sciences · 21.04.2026 · 123 (16)

DOI: 10.1073/pnas.2534844123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 15.04.2026. Verfasst von Tirza Bidany-Mizrahi und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Concern Foundation Laboratories, The Lautenberg Center for Immunology and Cancer Research, Department of Immunology and Cancer Research, Faculty …. Hauptthemen laut MEDLINE: WW Domain-Containing Oxidoreductase, Epithelial-Mesenchymal Transition, Skin Neoplasms, Tumor Suppressor Proteins. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: EC | European Research Council (ERC), Associazione italiana per la Riccerca contro il Cancro (AICR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cutaneous squamous cell carcinoma (cSCC), the second most common skin cancer, remains a major health burden worldwide. The WW domain–containing oxidoreductase (WWOX) is frequently altered in cancer; however, its role in epidermal biology and skin carcinogenesis remains undefined. Here, we uncover an essential function for WWOX in safeguarding epithelial identity and restraining cSCC progression. Using conditional knockout mice, we demonstrate that WWOX loss accelerates p53-driven cSCC, resulting in early, highly penetrant, and poorly differentiated tumors. Transcriptomic profiling revealed that WWOX deficiency drives epithelial-to-mesenchymal transition (EMT) and transcriptional plasticity, hallmarks of aggressive disease. Mechanistically, proximity ligation assays together with biochemical and cellular analyses support a close association between WWOX and p63 and imply that WWOX contributes to p63 stabilization; loss of WWOX reduces p63 protein levels and diminishes its binding to epithelial target genes, thereby disrupting epidermal transcriptional programs. Human tissue microarrays confirmed a concordant reduction of WWOX and p63 in advanced cSCC, correlating with poor differentiation. Functional assays in human keratinocytes and cSCC cells further showed that WWOX depletion enhances EMT plasticity, invasiveness, and metastatic colonization. Together, these findings identify WWOX as a critical regulator of epidermal integrity and reveal a previously unrecognized WWOX–p63 axis that constrains EMT and tumor progression in cSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

WW Domain-Containing OxidoreductaseEpithelial-Mesenchymal TransitionSkin NeoplasmsTumor Suppressor ProteinsEpidermisCarcinoma, Squamous CellAnimalsCutaneous Squamous Cell CarcinomaHumansMiceMice, KnockoutKeratinocytesTranscription FactorsGene Expression Regulation, NeoplasticTumor Suppressor Protein p53Cell Line, TumorTrans-Activators

Stichwörter der Autor:innen

EMTcutaneous squamous cell carcinomaknockoutp53p63

Substanzen

WW Domain-Containing OxidoreductaseTumor Suppressor ProteinsWWOX protein, humanTrp63 protein, mouseWwox protein, mouseTP63 protein, humanTranscription FactorsTumor Suppressor Protein p53Trans-Activators

Autor:innen und Institutionen

  • The Concern Foundation Laboratories, The Lautenberg Center for Immunology and Cancer Research, Department of Immunology and Cancer Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Isra…
  • Department of Experimental Medicine and Surgery, University of Rome "Tor Vergata", Rome 00133, Italy.
  • Biochemistry Laboratory, Istituto di Ricovero e Cura a Carattere Scientifico-Istituto Dermopatico Immacolata, Rome 00133, Italy.
  • Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem 91120.
  • Department of Pathology, Hadassah University Hospital, Jerusalem 91120, Israel.
  • Cyprus Cancer Research Institute, Nicosia 2109, Cyprus.

ORCID-Profile: Tirza Bidany-Mizrahi, Mara Mancini, Osama Hidmi, Gerry Melino, Eleonora Candi, Rami I Aqeilan

Förderung

  • EC | European Research Council (ERC)
  • Associazione italiana per la Riccerca contro il Cancro (AICR)

Zitieren

APA

Bidany-Mizrahi, T., Maroun, K., Mancini, M., Hidmi, O., Ansari, I., Monin, J., Keidar Haran, T., Maly, A., Melino, G., Candi, E., & Aqeilan, R. I. (2026). WWOX maintains epidermal identity and suppresses EMT to prevent aggressive cutaneous squamous cell carcinoma. Proceedings of the National Academy of Sciences, 123(16). https://doi.org/10.1073/pnas.2534844123

Vancouver

Bidany-Mizrahi T, Maroun K, Mancini M, Hidmi O, Ansari I, Monin J, et al. WWOX maintains epidermal identity and suppresses EMT to prevent aggressive cutaneous squamous cell carcinoma. Proceedings of the National Academy of Sciences. 2026;123(16). doi:10.1073/pnas.2534844123

BibTeX
@article{BidanyMizrahi2026,
  author = {Bidany-Mizrahi, Tirza and Maroun, Kian and Mancini, Mara and Hidmi, Osama and Ansari, Ihab and Monin, Jonathan and Keidar Haran, Tal and Maly, Alexander and Melino, Gerry and Candi, Eleonora and Aqeilan, Rami I},
  title = {WWOX maintains epidermal identity and suppresses EMT to prevent aggressive cutaneous squamous cell carcinoma},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {16},
  doi = {10.1073/pnas.2534844123}
}
Kostenlos starten →